Hepatitis Diagnostic Test Market -Sophisticated Opportunities 2028 | MedMira, Inc., Danaher Corporation
The global hepatitis diagnostic test market is prognosticated to witness a surge in its demand during the forecast period 2018-2028. The rising incidence of hepatitis A, B, and C in comparison to D and E, in the last decade, has fuelled the demand for hepatitis diagnostic tests around the world. Hepatitis is a medical condition in which the liver swells up, leading to other types of complications such as liver failure, anorexia, cirrhosis, and jaundice. It has been observed that nearly 300 million people across the world are infected to any one form of hepatitis, thus pushing the need for hepatitis diagnostic test in various parts of the country. According to the World Health Organization, nearly 500,000 people die on a yearly basis due to hepatitis. The increasing awareness about the disease and its symptoms will fuel the demand for hepatitis diagnostic tests.
Request Sample Copy of the Report @
The global hepatitis diagnostics test market is likely to expand at 6.5% CAGR during the forecast period. According to TMR Research, the market is likely to reach US$6.9 bn by the end of 2028.
Hepatitis Diagnostic Test Market: Trends and Opportunities
Various bodies such as government, non-profitable organizations, and NGOs, play an important role in the global hepatitis diagnostics test market. These bodies help in creating awareness about various medical conditions by providing correct information associated to the symptoms and detection techniques. Rise in awareness regarding the disease positively impacts the market. Apart from these, technological advancements such as molecular diagnostics comprising RNA and DNA testing are promoting the market growth.
Request TOC of the Report @
However, it has been noticed that the prevalence of hepatitis type B and C is excessively high in countries with middle-income and low income. A few of the African and Asian countries do fall in this category. Lack of skilled labors accompanied with high cost for test is likely to hinder the market’s growth in the future. Techniques such as PCR, CLIA, ELISA, and RIBA which are used to perform immunoassays are not cheap, which makes them expensive for patients and their families in underdeveloped countries. This may restrict the market’s trajectory to an extent. Nevertheless, liver function tests which are the first line detection for this disease is likely to push the market during the assessed period.
Global Hepatitis Diagnostic Test Market: Market Potential
Recently, the US Food and Drug Administration has given a nod to a pair of assays which are designated for the use with an immunodiagnostic system which is known to spot HBV in individuals. These move has offered the physicians and patients of consolidating all their test onto Ortho’s VITROSs system. This is likely to make consumers more aware about the disease in future.
Global Hepatitis Diagnostics Test Market: Regional Outlook
On the basis of geography, North America held the largest share in terms of revenue in 2016. Early adoption of advanced technologies and high level of awareness among consumers about novel therapeutics and diagnostic tests is contributing to the growth of market in the region. Initiatives by non-government and government organizations in Canada are also contributing to the growth of the market in the region. For example, The Public Health Agency of Canada conducted the World Hepatitis Day for creating awareness regarding hepatitis detection, this has positively impacted the demand for hepatitis diagnostic tests in the country. It is predicted that Asia Pacific is going to witness a surge in demand for detection techniques in the coming years.
Read Comprehensive Overview of Report @
Global Hepatitis Diagnostics Test Market: Competitive Landscape
There are few players in the market who are dominating the market through strategic partnership and acquisitions with regional or local players in an aim to expand their footprints in various regions. Major players in the market are Abbott Laboratories, MedMira, Inc., Danaher Corporation, Bio Rad Laboratories, and DiaSorin S.p. A.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis Diagnostic Test Market -Sophisticated Opportunities 2028 | MedMira, Inc., Danaher Corporation here
News-ID: 1364457 • Views: 88
More Releases from TMR Research
Mobile Handset Protection Market Latest Report On Challenges 2025 | SquareTrade, …
Global Mobile Handset Protection Market: Snapshot Today, mobile phones have become integral to everyday functioning in a communication-driven ecosystem. This has necessitated the need for appropriate security measures for protection against device theft, damage, or misuse. Moreover, at the corporate level, the introduction of practices such as enterprise mobility and bring your own device (BYOD) has widened the application scope of smartphones. This has surfaced as a growth opportunity for product
Portable Gas Chromatograph Market Challenges On Upcoming Trends 2025 | Agilent T …
Global Portable Gas Chromatograph Market: Snapshot Applications of gas chromatograph techniques have witnessed a tremendous rise in areas such as production monitoring, research, petrochemical, quality check in the chemicals industry, effluent management in the industrial sector, and forensic science. While the conventional stationary, laboratory desk-top, process at-line and on-line chromatographs of a variety of sizes and configurations are still ubiquitous across key application sectors, the increased need for effective on-field analytical
Video Content Analytics Market 2025 | Cisco (U.S.), ADT security (U.S.), HikVisi …
Global Video Content Analytics Market: Snapshot The global security and surveillance industry is expanding at a massive pace and is transforming from legacy CCTV surveillance systems to fully digital, advanced network-based video surveillance systems. Historical shipment data reveals that over 2 bn security camera are operating across the world at any given time and the numbers are constantly rising. With this exponentially rise in camera numbers, the practice of making use
Intravenous Iron Drugs Market Drivers, End User, Key Players and Challenges by 2 …
Intravenous Iron Drugs Market: Snapshot Iron is one of the most significant minerals required for the correct working of human bodies. Iron insufficiency prompts various medical problems, for example, anemia and could have a grave and direct association with the several of hospitalizations and deaths. The global market for intravenous drugs is foreseen to display a solid CAGR over the report's forecast period attributable to the rising pervasiveness of anemia cases
More Releases for Hepatitis
Hepatitis E Therapeutics Pipeline Analysis 2018
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to
Hepatitis Drugs Market Opportunity Assessment Study
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in
Global Hepatitis A Vaccine Sales Market Report
In this report, the global Hepatitis A Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2013
Hepatitis B Vaccines Market Growth Analysis 2021
Hepatitis B refers to an infectious disease that is caused by hepatitis B virus. Symptoms of this disease are not visible in initial stages and develop after few weeks only. Hepatitis B virus is transmitted by exposure to infectious blood or body fluids of an infected person. This disease may even occur from the birth. Hepatitis B may be caused by blood transfusions, healthcare setting, sharing razors and dialysis. Hepatitis
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Global Hepatitis C Drug Sales Market 2017
In this report, the Global Hepatitis C Drug Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis C Drug for these regions, from 2012